7-145660202-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000688801.3(ENSG00000230746):​n.452+20907C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 151,904 control chromosomes in the GnomAD database, including 41,653 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.74 ( 41653 hom., cov: 30)

Consequence

ENSG00000230746
ENST00000688801.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.86

Publications

1 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000688801.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.1).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000688801.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000230746
ENST00000688801.3
n.452+20907C>G
intron
N/A
ENSG00000230746
ENST00000839561.1
n.286-11806C>G
intron
N/A
ENSG00000230746
ENST00000839562.1
n.398-11806C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.737
AC:
111923
AN:
151786
Hom.:
41621
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.844
Gnomad AMI
AF:
0.770
Gnomad AMR
AF:
0.673
Gnomad ASJ
AF:
0.713
Gnomad EAS
AF:
0.573
Gnomad SAS
AF:
0.616
Gnomad FIN
AF:
0.707
Gnomad MID
AF:
0.791
Gnomad NFE
AF:
0.713
Gnomad OTH
AF:
0.732
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.737
AC:
112010
AN:
151904
Hom.:
41653
Cov.:
30
AF XY:
0.733
AC XY:
54388
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.845
AC:
35007
AN:
41452
American (AMR)
AF:
0.672
AC:
10255
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.713
AC:
2468
AN:
3460
East Asian (EAS)
AF:
0.573
AC:
2937
AN:
5126
South Asian (SAS)
AF:
0.616
AC:
2962
AN:
4806
European-Finnish (FIN)
AF:
0.707
AC:
7460
AN:
10546
Middle Eastern (MID)
AF:
0.782
AC:
230
AN:
294
European-Non Finnish (NFE)
AF:
0.713
AC:
48450
AN:
67946
Other (OTH)
AF:
0.729
AC:
1539
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1451
2902
4352
5803
7254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.639
Hom.:
1729
Bravo
AF:
0.741

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.1
CADD
Benign
0.23
DANN
Benign
0.27
PhyloP100
-2.9

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4595039;
hg19: chr7-145357295;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.